Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-010812
Filing Date
2025-04-16
Accepted
2025-04-16 16:41:19
Documents
2
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 form3-04162025_080414.html 3  
1 form3-04162025_080414.xml 3 18624
2 ex24-04162025_080414.htm EX-24 5335
  Complete submission text file 0001415889-25-010812.txt   25430
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE CT, STE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Chiang Pichi Luo (Reporting) CIK: 0002064744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38542 | Film No.: 25843277